BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18619676)

  • 21. IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance.
    Shiokawa A; Tanabe K; Tsuji NM; Sato R; Hachimura S
    Immunol Lett; 2009 Jun; 125(1):7-14. PubMed ID: 19446579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anatomy of mucosal immune responses.
    Garside P; Millington O; Smith KM
    Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph node.
    Lee HS; Kim HR; Lee EH; Jang MH; Kim SB; Park JW; Seoh JY; Jung YJ
    Immunobiology; 2012 Apr; 217(4):402-11. PubMed ID: 22196895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes.
    Zea AH; Rodriguez PC; Culotta KS; Hernandez CP; DeSalvo J; Ochoa JB; Park HJ; Zabaleta J; Ochoa AC
    Cell Immunol; 2004; 232(1-2):21-31. PubMed ID: 15922712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein.
    Hall HT; Sjölin H; Brauner H; Tomasello E; Dalod M; Vivier E; Höglund P
    Eur J Immunol; 2008 Nov; 38(11):3191-9. PubMed ID: 18925576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothesis: TCR signal transduction--A novel tri-modular signaling system.
    Amon MA; Manolios N
    Mol Immunol; 2008 Feb; 45(4):876-80. PubMed ID: 17915329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ effector T cell distribution in vivo: TGF-beta 1/TGF-beta receptor II interaction during activation mediates accumulation in the target tissue by preferential proliferation.
    Bode U; Tiedemann K; Westermann J
    Eur J Immunol; 2004 Apr; 34(4):1050-8. PubMed ID: 15048715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses.
    McNeill L; Salmond RJ; Cooper JC; Carret CK; Cassady-Cain RL; Roche-Molina M; Tandon P; Holmes N; Alexander DR
    Immunity; 2007 Sep; 27(3):425-37. PubMed ID: 17719247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyporesponsiveness of CD4 T cells induced in oral tolerance is maintained by selective impairment in the TCR-induced calcium/NFAT signaling pathway resulting from caspase activation.
    Hachimura S; Kaji T; Asai K; Ise W; Nakayama T; Kaminogawa S
    Ann N Y Acad Sci; 2004 Dec; 1029():344-5. PubMed ID: 15681776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deficiency of the CD3-TCR signal pathway in three patients with idiopathic CD4+ lymphocytopenia].
    Hubert P; Bergeron F; Grenot P; Seligman M; Krivitzky A; Debré P; Autran B
    J Soc Biol; 1999; 193(1):11-6. PubMed ID: 10851550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCR down-regulation controls T cell homeostasis.
    Boding L; Bonefeld CM; Nielsen BL; Lauritsen JP; von Essen MR; Hansen AK; Larsen JM; Nielsen MM; Odum N; Geisler C
    J Immunol; 2009 Oct; 183(8):4994-5005. PubMed ID: 19801521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous T cell receptor signaling required for synapse maintenance and full effector potential.
    Huppa JB; Gleimer M; Sumen C; Davis MM
    Nat Immunol; 2003 Aug; 4(8):749-55. PubMed ID: 12858171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha.
    Clark JM; Annenkov AE; Panesar M; Isomäki P; Chernajovsky Y; Cope AP
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1696-701. PubMed ID: 14745016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dynamic immunological synapse mediates homeostatic TCR-dependent and -independent signaling.
    Storim J; Bröcker EB; Friedl P
    Eur J Immunol; 2010 Oct; 40(10):2741-50. PubMed ID: 20821730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered production of immunoregulatory cytokines by invariant Valpha19 TCR-bearing cells dependent on the duration and intensity of TCR engagement.
    Shimamura M; Huang YY; Kobayashi M; Goji H
    Int Immunol; 2009 Feb; 21(2):179-85. PubMed ID: 19106232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.